We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Extends Expiration Dates of Sodium Bicarbonate Injectables in Shortage
FDA Extends Expiration Dates of Sodium Bicarbonate Injectables in Shortage
Following Hospira’s recall last month of sterile sodium bicarbonate injections, the FDA has extended the expiration dates for more than 90 lots to help alleviate a critical shortage of injectable drugs.